Combinatorial vaccine strategies and the use of molecular arrays to characterize T-cell activation.
Schlom
J
J
Laboratory of Tumour Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. js141c@nih.gov
Palena
C
C
Greiner
J W
JW
Tsang
K Y
KY
Grosenbach
D W
DW
Sabzevari
H
H
Gulley
J L
JL
Arlen
P M
PM
Kass
E
E
Hodge
J W
JW
D000276:Adjuvants, Immunologic / Q000008:administration & dosage; D000818:Animals; D000915:Antibody Affinity; D000951:Antigens, Neoplasm / Q000235:genetics; D019496:Cancer Vaccines / Q000235:genetics / Q000276:immunology*; D002986:Clinical Trials as Topic; D000939:Epitopes / Q000276:immunology; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000008:administration & dosage; D006801:Humans; D008213:Lymphocyte Activation; D051379:Mice; D008822:Mice, Transgenic; D013601:T-Lymphocytes / Q000276:immunology*; D014614:Vaccines, Synthetic / Q000276:immunology*
D000276:Adjuvants, Immunologic; D000951:Antigens, Neoplasm; D019496:Cancer Vaccines; D000939:Epitopes; D014614:Vaccines, Synthetic; D016178:Granulocyte-Macrophage Colony-Stimulating Factor